Pres, Prod Dev & Med Aff & CMO of Exelixis, Inc. (NASDAQ:EXEL), Schwab Gisela, sells 50,000 shares worth $1,117,500
According to Exelixis, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 19 07:57 PM, company Pres, Prod Dev & Med Aff & CMO, Schwab Gisela disclosed selling 50,000 shares at a cost of $22.35. At the time of this transaction (Feb 18), this trade was worth $1,117,500 in total. As of Feb 18, Schwab Gisela now owns 540,597 shares in total worth about $12,006,659.370000001.
For the last few recent trades made by Exelixis, Inc. (NASDAQ:EXEL) Pres, Prod Dev & Med Aff & CMO, Schwab Gisela, we have the following information:
- SEC Form 4 filing: Jun 04: Sold 100,000 shares at the rate of $22.96 per share. Total worth of this trade was $2,296,000. Total number of shares owned as of Jun 04 were 325,963
- SEC Form 4 filing: Apr 23: Sold 100,000 shares at the rate of $26.00 per share. Total worth of this trade was $2,600,000. Total number of shares owned as of Apr 23 were 325,122
- SEC Form 4 filing: Mar 04: Sold 100,000 shares at the rate of $19.40 per share. Total worth of this trade was $1,940,000. Total number of shares owned as of Mar 04 were 325,122
Posted by
George Daniels
on Saturday February 20 2021, 7:54 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
